KRAS and familial pancreatic carcinoma: Guided by these fundamental insights and molecular principles learned from developmental biology and evolutionary biology, we lay out an alternative strategy to control oncogenic K-RAS hyperactivation and eradicate oncogenic K-RAS-driven tumors in pancreatic cancer [72].